These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34073695)

  • 21. Fecal Transplants by Colonoscopy and Capsules Are Cost-Effective Strategies for Treating Recurrent Clostridioides difficile Infection.
    Luo Y; Lucas AL; Grinspan AM
    Dig Dis Sci; 2020 Apr; 65(4):1125-1133. PubMed ID: 31493042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
    Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
    J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
    Merlo G; Graves N; Brain D; Connelly LB
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1927-1932. PubMed ID: 27043242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    Brandt LJ; Aroniadis OC; Mellow M; Kanatzar A; Kelly C; Park T; Stollman N; Rohlke F; Surawicz C
    Am J Gastroenterol; 2012 Jul; 107(7):1079-87. PubMed ID: 22450732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?
    Lin Z; Iqbal Z; Ortiz JF; Khan SA; Jahan N
    Cureus; 2020 Aug; 12(8):e9653. PubMed ID: 32923252
    [No Abstract]   [Full Text] [Related]  

  • 27. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent
    Shin JH; Chaplin AS; Hays RA; Kolling GL; Vance S; Guerrant RL; Archbald-Pannone L; Warren CA
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31315214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clostridium difficile.
    Curry SR
    Clin Lab Med; 2017 Jun; 37(2):341-369. PubMed ID: 28457354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Fecal Microbiota Transplant Have a Role in Treating Recurrent
    Vedala K; Sobash P; Shah P; Kamoga GR
    Front Public Health; 2021; 9():670941. PubMed ID: 34178927
    [No Abstract]   [Full Text] [Related]  

  • 31. A Systematic Review of Fecal Microbiota Transplantation Versus Vancomycin for Treatment of Recurrent Clostridioides difficile Infection.
    Leung J; Pham S
    Gastroenterol Nurs; 2021 Mar-Apr 01; 44(2):106-115. PubMed ID: 33795620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridioides
    Gawey BJ; Khanna S
    Gastroenterol Hepatol (N Y); 2023 Jun; 19(6):319-328. PubMed ID: 37706187
    [No Abstract]   [Full Text] [Related]  

  • 33. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
    Chauhan A; Apostolov R; van Langenberg D; Garg M
    Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Freeze-dried fecal samples are biologically active after long-lasting storage and suited to fecal microbiota transplantation in a preclinical murine model of
    Reygner J; Charrueau C; Delannoy J; Mayeur C; Robert V; Cuinat C; Meylheuc T; Mauras A; Augustin J; Nicolis I; Modoux M; Joly F; Waligora-Dupriet AJ; Thomas M; Kapel N
    Gut Microbes; 2020 Sep; 11(5):1405-1422. PubMed ID: 32501140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridioides difficile Infection in the Neurorehabilitation Setting: Importance of a Multidisciplinary Approach and Impact of the Fecal Microbiota Transplantation.
    Secondo D; Massaro D; Verrienti G; Perri F; Biscaglia G
    Cureus; 2023 Oct; 15(10):e46574. PubMed ID: 37937006
    [No Abstract]   [Full Text] [Related]  

  • 37. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
    Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E
    Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
    Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
    mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
    Youngster I; Mahabamunuge J; Systrom HK; Sauk J; Khalili H; Levin J; Kaplan JL; Hohmann EL
    BMC Med; 2016 Sep; 14(1):134. PubMed ID: 27609178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent
    Peri R; Aguilar RC; Tüffers K; Erhardt A; Link A; Ehlermann P; Angeli W; Frank T; Storr M; Glück T; Sturm A; Rosien U; Tacke F; Bachmann O; Solbach P; Stallmach A; Goeser F; Vehreschild MJ;
    United European Gastroenterol J; 2019 Jun; 7(5):716-722. PubMed ID: 31210950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.